MedTrace Logo

Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges

NCT02193178 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2020-07-29

Study results available
· View outcomes & findings →

Summary

The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

comfilcon A Toric

Contact lenses

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Jan Bergmanson, OD PhD · Texas Eye Research and Technology Center (TERTC), School of Optometry, University of Houston

  • Pete Kollbaum, OD PhD · Clinical Optics Research Lab (CORL), Indiana University School of Optometry, Indiana University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02193178 on ClinicalTrials.gov